BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23825490)

  • 21. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer.
    Aktan-Collan K; Haukkala A; Mecklin JP; Uutela A; Kääriäinen H
    J Med Genet; 2001 Nov; 38(11):787-92. PubMed ID: 11732490
    [No Abstract]   [Full Text] [Related]  

  • 22. Hereditary non-polyposis colon cancer.
    Devlin LA; Price JH; Morrison PJ
    Ulster Med J; 2005 May; 74(1):14-21. PubMed ID: 16025587
    [No Abstract]   [Full Text] [Related]  

  • 23. [When and how to investigate a mutation predisposing to the Lynch syndrome].
    Robert-Grandpierre F; Bressoud A; Hutter P; Tschantz P
    Rev Med Suisse Romande; 2001 May; 121(5):357-60. PubMed ID: 11450192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Colorectal cancer: when and how to look for hereditary nonpolyposis colorectal neoplasm syndrome?].
    Jaïs P
    Gastroenterol Clin Biol; 1999 Feb; 23(2):284-6. PubMed ID: 10353029
    [No Abstract]   [Full Text] [Related]  

  • 25. New diagnostic criteria for HNPCC are on the way.
    Kuska B
    J Natl Cancer Inst; 1997 Jan; 89(1):11-2. PubMed ID: 8978400
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].
    Sebastian M; Niederle N; Thomas M; Reck M; Schmittel A; Fischer B; Overbeck T; Gröschel A; Deppermann M; Pirker R; Huber RM; Eberhardt W; Griesinger F
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2096-100. PubMed ID: 25268213
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
    Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
    Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do we approach the goal of identifying everybody with Lynch syndrome?
    Hampel H; de la Chapelle A
    Fam Cancer; 2013 Jun; 12(2):313-7. PubMed ID: 23568035
    [No Abstract]   [Full Text] [Related]  

  • 31. Basic concepts for genetic testing in common hereditary colorectal cancer syndromes.
    Markey K; Axel L; Ahnen D
    Curr Gastroenterol Rep; 2002 Oct; 4(5):404-13. PubMed ID: 12228043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risk analysis in families with hereditary nonpolyposis colorectal cancer.
    Köküer M; Naguib RN; Jancovic P; Younghusband HB; Green RC
    IEEE Trans Inf Technol Biomed; 2006 Jul; 10(3):581-7. PubMed ID: 16871728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic counseling].
    Utsunomiya J; Minegishi M
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):967-72. PubMed ID: 16044957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New genetic test for Lynch syndrome.
    Kerr C
    Lancet Oncol; 2006 Nov; 7(11):892. PubMed ID: 17099981
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic testing by cancer site: colon (nonpolyposis syndromes).
    Senter L
    Cancer J; 2012; 18(4):334-7. PubMed ID: 22846734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling.
    Keller M; Jost R; Kadmon M; Wüllenweber HP; Haunstetter CM; Willeke F; Jung C; Gebert J; Sutter C; Herfarth C; Büchler MW
    Dis Colon Rectum; 2004 Feb; 47(2):153-62. PubMed ID: 15043284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current applications of genetic technology in predisposition testing and microsatellite instability assays.
    Frazier ML; Su LK; Amos CI; Lynch PM
    J Clin Oncol; 2000 Nov; 18(21 Suppl):70S-4S. PubMed ID: 11060331
    [No Abstract]   [Full Text] [Related]  

  • 38. Lynch syndrome in the 21st century: clinical perspectives.
    Tiwari AK; Roy HK; Lynch HT
    QJM; 2016 Mar; 109(3):151-8. PubMed ID: 26224055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases].
    Pierer M; Baerwald C; Wagner U
    Z Rheumatol; 2009 Nov; 68(9):758-62. PubMed ID: 19838714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic risk profile of sarcoidosis].
    Fischer A; Zissel G; Nebel A; Müller-Quernheim J
    Internist (Berl); 2014 Feb; 55(2):135-40. PubMed ID: 24217528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.